Delivery Order SPE2DB22D1017-SPE2DB23FF6YV
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,353.39, is for the delivery of LUMIGAN 0.01% eye drops in 5 milliliter packaging. The contract is a Firm Fixed Price Delivery Order with a completion date of February 18, 2022. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order with a Firm Fixed Price valued at $1,574.97. The contract is for the supply of LUMIGAN 0.01% Eye Drops 2.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The award has an ultimate completion date of May 16, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a $3,391.99 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of LUMIGAN 0.01% eye drops, a specialty ophthalmic medication, in support of federal healthcare programs. The contract has an ultimate completion date of June 13, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,079.64 for the supply of Lumigan 0.01% eye drops. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 11, 2022. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award is for the delivery of LUMIGAN 0.01% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,457.37, was made to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 21, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,032.70 firm fixed-price delivery order is for the pharmaceutical product LUMIGAN 0.01% Eye Drops 2.5ML. The award has an ultimate completion date of October 25, 2023. Amerisourcebergen is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,975.37 firm fixed-price delivery order is for the supply of LUMIGAN 0.01% eye drops, a prescription ophthalmic medication. The contract has an ultimate completion date of July 16, 2024 and was awarded on July 15, 2024. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,495.92, for the delivery of LUMIGAN 0.01% Eye Drops 5ML. The award has an ultimate completion date of June 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,361.88 firm fixed-price contract is for the delivery of LUMIGAN 0.01% eye drops, a prescription medication, to support federal healthcare programs. The contract has an ultimate completion date of January 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,741.16, is for the supply of LUMIGAN 0.01% eye drops in 5 ML containers. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB23FF6YVDelivery Order
This federal contract award, valued at $1,190.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of LUMIGAN 0.01% eye drops, a pharmaceutical product. The contract has an ultimate completion date of May 15, 2023 and is structured as a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, Cencora, Inc. (the parent company) holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs enable the efficient procurement of essential pharmaceutical and medical supplies to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 5/12/23 |